Group 1 - The company Xiangyuan New Materials (SZ 300980) announced that its fourth board meeting will be held on December 9, 2025, to review the proposal for the fourth extraordinary shareholders' meeting of 2025 [1] - For the first half of 2025, the company's revenue composition is entirely from rubber and plastic products, accounting for 100.0% [1] - As of the report date, the market capitalization of Xiangyuan New Materials is 3.6 billion yuan [1] Group 2 - The article highlights a significant issue in the pharmaceutical industry regarding the abuse of pregabalin, marking the first reported case of addiction in China [1] - It points out vulnerabilities in online platforms that allow the purchase of medications without medical records, raising concerns about regulatory oversight [1] - The classification of pregabalin and the need for scientific evaluation regarding its regulation are emphasized [1]
祥源新材：12月9日召开董事会会议